Wordt geladen...
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
A subset of poor-prognosis medulloblastoma has genomic amplification of MYC. MYC regulates glutamine metabolism in multiple cellular contexts. We modified the glutamine analog 6-diazo-5-oxo-l-norleucine (DON) to mask its carboxylate and amine functionalities, creating a prodrug termed JHU-083 with i...
Bewaard in:
| Gepubliceerd in: | Transl Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Neoplasia Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657308/ https://ncbi.nlm.nih.gov/pubmed/31340195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.05.013 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|